These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 14698849)

  • 21. Induction of IL-1 receptor antagonist by interferon beta: implication for the treatment of multiple sclerosis.
    Sciacca FL; Canal N; Grimaldi LM
    J Neurovirol; 2000 May; 6 Suppl 2():S33-7. PubMed ID: 10871782
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Type I interferons inhibit interleukin-10 production in activated human monocytes and stimulate IL-10 in T cells: implications for Th1-mediated diseases.
    Feng X; Yau D; Holbrook C; Reder AT
    J Interferon Cytokine Res; 2002 Mar; 22(3):311-9. PubMed ID: 12034038
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The identification of a small molecule inhibitor that specifically reduces T cell-mediated adaptive but not LPS-mediated innate immunity by T cell membrane-monocyte contact bioassay.
    Li YY; Bao M; Meurer J; Skuballa W; Bauman JG; Doecke WD; Zollner TM
    Immunol Lett; 2008 Apr; 117(1):114-8. PubMed ID: 18241931
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selective induction of interleukin-1 receptor antagonist and interleukin-8 in human monocytes by normal polyspecific IgG (intravenous immunoglobulin).
    Ruiz de Souza V; Carreno MP; Kaveri SV; Ledur A; Sadeghi H; Cavaillon JM; Kazatchkine MD; Haeffner-Cavaillon N
    Eur J Immunol; 1995 May; 25(5):1267-73. PubMed ID: 7774630
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The production of IL-1 receptor antagonist in IFN-beta-stimulated human monocytes depends on the activation of phosphatidylinositol 3-kinase but not of STAT1.
    Molnarfi N; Hyka-Nouspikel N; Gruaz L; Dayer JM; Burger D
    J Immunol; 2005 Mar; 174(5):2974-80. PubMed ID: 15728510
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human Th1 cells preferentially induce interleukin (IL)-1beta while Th2 cells induce IL-1 receptor antagonist production upon cell/cell contact with monocytes.
    Chizzolini C; Chicheportiche R; Burger D; Dayer JM
    Eur J Immunol; 1997 Jan; 27(1):171-7. PubMed ID: 9022014
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytokine induction of the ability of human monocyte CD44 to bind hyaluronan is mediated primarily by TNF-alpha and is inhibited by IL-4 and IL-13.
    Levesque MC; Haynes BF
    J Immunol; 1997 Dec; 159(12):6184-94. PubMed ID: 9550421
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of monocyte IL-10 synthesis by endogenous IL-1 and TNF-alpha: role of the p38 and p42/44 mitogen-activated protein kinases.
    Foey AD; Parry SL; Williams LM; Feldmann M; Foxwell BM; Brennan FM
    J Immunol; 1998 Jan; 160(2):920-8. PubMed ID: 9551930
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Th1 and Th2 cytokines IFN-gamma and IL-4 antagonize the inhibition of monocyte IL-1 receptor antagonist by glucocorticoids: involvement of IL-1.
    Kovalovsky D; Páez Pereda M; Sauer J; Perez Castro C; Nahmod VE; Stalla GK; Holsboer F; Arzt E
    Eur J Immunol; 1998 Jul; 28(7):2075-85. PubMed ID: 9692875
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gram-positive and gram-negative bacteria do not trigger monocytic cytokine production through similar intracellular pathways.
    Rabehi L; Irinopoulou T; Cholley B; Haeffner-Cavaillon N; Carreno MP
    Infect Immun; 2001 Jul; 69(7):4590-9. PubMed ID: 11402003
    [TBL] [Abstract][Full Text] [Related]  

  • 31. T cell lymphokine-induced secretion of cytokines by monocytes from patients with multiple sclerosis.
    Maimone D; Reder AT; Gregory S
    Cell Immunol; 1993 Jan; 146(1):96-106. PubMed ID: 8425234
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunomodulatory properties of human serum immunoglobulin A: anti-inflammatory and pro-inflammatory activities in human monocytes and peripheral blood mononuclear cells.
    Olas K; Butterweck H; Teschner W; Schwarz HP; Reipert B
    Clin Exp Immunol; 2005 Jun; 140(3):478-90. PubMed ID: 15932509
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Whole blood production of monocytic cytokines (IL-1beta, IL-6, TNF-alpha, sIL-6R, IL-1Ra) in haemodialysed patients.
    Le Meur Y; Lorgeot V; Aldigier JC; Wijdenes J; Leroux-Robert C; Praloran V
    Nephrol Dial Transplant; 1999 Oct; 14(10):2420-6. PubMed ID: 10528667
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predominant role of tumor necrosis factor-alpha in human monocyte IL-10 synthesis.
    Wanidworanun C; Strober W
    J Immunol; 1993 Dec; 151(12):6853-61. PubMed ID: 8258695
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apolipoprotein A-I inhibits the production of interleukin-1beta and tumor necrosis factor-alpha by blocking contact-mediated activation of monocytes by T lymphocytes.
    Hyka N; Dayer JM; Modoux C; Kohno T; Edwards CK; Roux-Lombard P; Burger D
    Blood; 2001 Apr; 97(8):2381-9. PubMed ID: 11290601
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aloe vera downregulates LPS-induced inflammatory cytokine production and expression of NLRP3 inflammasome in human macrophages.
    Budai MM; Varga A; Milesz S; Tőzsér J; Benkő S
    Mol Immunol; 2013 Dec; 56(4):471-9. PubMed ID: 23911403
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-inflammatory properties of human serum IgA: induction of IL-1 receptor antagonist and Fc alpha R (CD89)-mediated down-regulation of tumour necrosis factor-alpha (TNF-alpha) and IL-6 in human monocytes.
    Wolf HM; Hauber I; Gulle H; Samstag A; Fischer MB; Ahmad RU; Eibl MM
    Clin Exp Immunol; 1996 Sep; 105(3):537-43. PubMed ID: 8809146
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel MEK2/PI3Kδ pathway controls the expression of IL-1 receptor antagonist in IFN-β-activated human monocytes.
    Brandt KJ; Carpintero R; Gruaz L; Molnarfi N; Burger D
    J Leukoc Biol; 2010 Dec; 88(6):1191-200. PubMed ID: 20837746
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interferon-beta regulates cytokines and BDNF: greater effect in relapsing than in progressive multiple sclerosis.
    Hamamcioglu K; Reder AT
    Mult Scler; 2007 May; 13(4):459-70. PubMed ID: 17463069
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interleukin-13 effects on activated monocytes lead to novel cytokine secretion profiles intermediate between those induced by interleukin-10 and by interferon-gamma.
    Minty A; Ferrara P; Caput D
    Eur Cytokine Netw; 1997 Jun; 8(2):189-201. PubMed ID: 9262968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.